REDWOOD CITY, Calif., April 2, 2020 /PRNewswire/ -- Nevro Corp. ("Nevro") (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of ...
The findings were published in Neuromodulation: Technology at the Neural Interface, a peer-reviewed publication of the International Neuromodulation Society. The 83-patient study evaluated patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback